TITLE

Formative research to shape HPV vaccine introduction strategies in Peru

AUTHOR(S)
Bartolini, Rosario M.; Drake, Jennifer Kidwell; Creed-Kanashiro, Hilary M.; Díaz-Otoya, Margarita M.; Mosqueira-Lovón, Nelly Rocío; Penny, Mary E.; Winkler, Jennifer L.; LaMontagne, Scott; Bingham, Allison
PUB. DATE
May 2010
SOURCE
Salud Pública de México;may2010, Vol. 52 Issue 3, p226
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objetivo. Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. Material y métodos. Investigación formativa usando técnicas cualitativas y cuantitativas. Los participantes incluyeron niños, padres, líderes, funcionarios del sector salud y educación, y diseñadores de políticas. Resultados. Generalmente se apoya la introducción de la vacuna contra el VPH, dado que se aprecian los beneficios de la vacunación y se desea prevenir el cáncer. En la comunidad se encontraron preocupaciones sobre seguridad, confianza y calidad de atención. El sistema de inmunizaciones en el Perú es eficiente y tiene la capacidad para incluir la vacuna contra el VPH. Conclusiones. La investigación formativa permite comprender elementos clave que ayudan a diseñar un programa efectivo para la introducción de la vacuna contra el VPH.
ACCESSION #
51301061

 

Related Articles

  • Knowledge of Health Care Providers on HPV Related Issues in Cervical Cancer. HUSSAIN, F.; FLORA, M. S.; NAHAR, K.; KHAN, M. // Journal of Bangladesh College of Physicians & Surgeons;Oct2011, Vol. 29 Issue 4, p213 

    Background: The field of cervical cancer prevention is rapidly evolving because of identification of Human Papilloma Virus (HPV) as the necessary cause of disease. HPV vaccines are now in the market.For successful triggering of cervical cancer prevention program, HPV informations should be...

  • Recent trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel. Bassal, Ravit; Schejter, Eduardo; Bachar, Rachel; Shapira, Hagit; Kaufman, Zalman; Cohen, Dani; Keinan-Boker, Lital // Archives of Gynecology & Obstetrics;Aug2015, Vol. 292 Issue 2, p405 

    Purpose: This study describes time trends of cervical cancer and Cervical Intraepithelial Neoplasia 3 (CIN3) in Israel in the years 1986-2010 and characterizes these patients by demographics. Methods: A retrospective survey based on cervical cancer and CIN3 data documented in the computerized...

  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries. Natunen, Kari; Lehtinen, Johannes; Namujju, Proscovia; Sellors, John; Lehtinen, Matti // Infectious Diseases in Obstetrics & Gynecology;2011, Vol. 2011, Special section p1 

    Cervical cancer and other human papillomavirus- (HPV-) related cancers are preventable, but preventive measures implemented in developing countries and especially in low-income rural regions have not been effective. Cervical cancer burden derived from sexually transmitted HPV infections is the...

  • Cervical cancer rates higher than thought, study says.  // Journal of Business (10756124);6/5/2014, Vol. 29 Issue 12, p12 

    The article discusses a study by the University of Maryland School of Medicine which revealed that rates of cervical cancer in the U.S. are higher among American and African-American women aged 65- to 69-year-old. Topics include the 18.6 rates of cases of cervical cancer per 100,000 women,...

  • Cost-effective cervical cancer prevention possible in Brazil.  // PharmacoEconomics & Outcomes News;9/8/2007, Issue 536, p4 

    The article discusses research being done on the development of a cost effective strategy for cervical cancer prevention in Brazil. It references a study by S. J. Goldie et al. published in the August 2007 issue of the "Vaccine." The researchers concluded that a human papillomavirus (HPV)...

  • Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Bateman, Allen C.; Katundu, Katundu; Polepole, Pascal; Shibemba, Aaron; Mwanahamuntu, Mulindi; Dittmer, Dirk P.; Parham, Groesbeck P.; Chibwesha, Carla J. // Virology Journal;2015, Vol. 12 Issue 1, p81 

    Background The most common human papillomavirus (HPV) genotypes isolated from cervical cancer in select African countries are HPV-16, HPV-18, HPV-35, and HPV-45, but the most common genotypes in Zambia are unknown. The overall objective of this study was to assess the potential impact of current...

  • Epidemiology of cervical cancer in Latin America. Capote Negrin, Luis G. // Ecancermedicalscience;2015, Vol. 9 Issue 577-607, p1 

    The basic aspects of the descriptive epidemiology of cervical cancer in Latin America are presented. A decrease in the incidence and mortality rates has been observed in the period from 2000 to 2012 in all countries across the region, this has not occurred at the same proportions, and in many...

  • Genetic Variability in L1 and L2 Genes of HPV-16 and HPV-58 in Southwest China. Yaofei Yue; Hongying Yang; Kun Wu; Lijuan Yang; Junying Chen; Xinwei Huang; Yue Pan; Youqing Ruan; Yujiao Zhao; Xinan Shi; Qiangming Sun; Qihan Li // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    HPV account for most of the incidence of cervical cancer. Approximately 90% of anal cancers and a smaller subset (<50%) of other cancers (oropharyngeal, penile, vaginal, vulvar) are also attributed to HPV. The L1 protein comprising HPV vaccine formulations elicits high-titre neutralizing...

  • Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Hess, Paul; Boczkowski, David; Nair, Smita; Snyder, David; Gilboa, Eli // Cancer Immunology, Immunotherapy;Jun2006, Vol. 55 Issue 6, p672 

    Immunization of mice with dendritic cells transfected ex vivo with tumor-associated antigen (TAA)-encoding mRNA primes cytotoxic T lymphocytes (CTL) that mediate tumor rejection. Here we investigated whether direct injection of TAA mRNA, encapsulated in cationic liposomes, could function...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics